Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Capsule for curing aplastic anemia and its production method

An aplastic capsule technology, which is applied in blood diseases, medical formulas, medical preparations containing active ingredients, etc., can solve the problems of poor prognosis and high cost, and achieve the effect of convenient taking, simple taste, and no side effects

Inactive Publication Date: 2005-01-26
于敬来
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine treats with immunosuppressants, glucocorticoids, male hormones, and blood transfusions. Although some patients can temporarily relieve symptoms, with the reduction of hormone drugs, the symptoms reappear again. Some side effects caused by it are worrying. Twenty-seven side effects such as necrosis of the femoral head, endocrine disorders, diabetes, peptic ulcer, and low immune function, which are extremely expensive and have poor prognosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0016] Below with the specific situation of producing 1000 capsules and treating aplastic anemia with this capsule, the present invention is described in further detail:

[0017] In the first step, 400g of Astragalus membranaceus, 120g of cooked rhubarb, 200g of angelica, and 120g of Amomum are processed according to the law; in the second step, the astragalus, cooked rhubarb, angelica, and Amomum are mixed and decocted for three times, each time boiled For 30 minutes, combine the three medicinal liquids into liquid A; the third step is to evaporate the liquid A and concentrate to a concentrated liquid containing 1 g of the original drug per milliliter, add 1 times the amount of 95% ethanol and stir evenly, leave the precipitate for 12 hours to filter, and then Concentrate the filtrate under reduced pressure to recover ethanol, so that 4-6 grams of the original drug content per milliliter of the liquid is B liquid; the fourth step is to dilute the B liquid with water to contain...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a Chinese medicine capsule preparation for curing aplastic anemia. It is made up by using 6 Chinese medicinal materials of (by weight portion) 3 portions of notoginseng, 3 portions of amomum fruit, 1 portion of deerhorn glue, 5 portions of Chinese angelica root, 3 portions of coored rhubarb and 10 portions of astragalus root through the processes of separate pulverizing, decoction, concentration, filtering, alcohol extraction, recovering alcohol, concentration, precipitation, drying, mixing and capsulizing to obtain finished product with obvious therapeutic effect. Its effective rate is up to above 90%, and its effectual rate is up to above 60%, and for curing acute aplastic anemia its effective rate is up to 75%.

Description

(1) Technical field [0001] The invention relates to a capsule for treating aplastic anemia and a production process, which is a capsule prepared by extracting multi-flavored natural Chinese herbal medicines. (2) Background technology [0002] At present, aplastic anemia is a relatively common and refractory intractable disease among blood diseases, and its mortality rate is extremely high. It is still a difficult subject at home and abroad. Western medicine treats with immunosuppressants, glucocorticoids, male hormones, and blood transfusions. Although some patients can temporarily relieve symptoms, with the reduction of hormone drugs, the symptoms reappear again. Some side effects caused by it are worrying. Twenty-seven side effects such as femoral head necrosis, endocrine disorders, diabetes, peptic ulcer, and low immune function are extremely expensive and have poor prognosis. [0003] The purpose of the present invention is to develop a capsule for treating aplastic ane...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K35/32A61P7/06
Inventor 于敬来
Owner 于敬来
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com